GlaxoSmithKline's $5.1 Billion Tesaro Deal Spurs M&A Hopes

(Bloomberg) -- A little more than a month after a key index of biotechnology stocks suffered their worst session in more than seven years, GlaxoSmithKline Plc delivered some much-needed good news f...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.